You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 28, 2025

Profile for Colombia Patent: 6190524


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Colombia Patent: 6190524

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Nov 20, 2029 Merck Sharp Dohme BELSOMRA suvorexant
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of Patent CO6190524: Scope, Claims, and Patent Landscape in Colombia

Last updated: August 1, 2025

Introduction

Patent CO6190524, granted in Colombia, pertains to innovations in the pharmaceutical domain, specifically focusing on a novel drug formulation or therapeutic method. As the Colombian patent landscape becomes increasingly vital for pharmaceutical companies seeking market exclusivity and strategic positioning, a comprehensive understanding of this patent's scope, claims, and the broader legal environment is essential for stakeholders.

This analysis aims to dissect the scope and claims of patent CO6190524, contextualize its place within the Colombian patent landscape, and explore strategic implications for competitors, licensees, and patent holders.


I. Overview of Colombian Patent System for Pharmaceuticals

Colombia's patent law, aligned with international standards such as the TRIPS Agreement, allows patent protection for inventions that are novel, involve an inventive step, and are industrially applicable. Pharmaceutical patents are particular due to their complex composition and the nature of biological innovations.

The Colombian Patent Office (Superintendencia de Industria y Comercio, SIC) examines patent applications and grants patents usually spanning 20 years from the filing date. Patent landscapes for pharmaceuticals are heavily scrutinized, especially concerning patentability criteria, patent enforcement, and potential for patent linkage or compulsory licensing.


II. Patent CO6190524: General Information

  • Patent Title: Likely related to a drug formulation or therapeutic method.
  • Application Filing Date: Details required for precise timing relative to patent term and patent family.
  • Grant Date: Establishes patent validity period.
  • Patent Assignee/Owner: Information hints at the innovator or pharmaceutical entity.
  • Patent Number: CO6190524.

(Note: Without access to the exact patent document, this analysis synthesizes typical patent characteristics based on available public data sources.)


III. Scope of the Patent

1. Technological Field

Patent CO6190524 primarily resides within the pharmaceutical and medicinal chemistry domain, possibly concerning a specific drug compound, a novel formulation, a delivery system, or a therapeutic method.

2. Geographical Scope

  • National Coverage: The patent protection is exclusive within Colombia only.
  • Extension Possibilities: Potential for the patent to be part of an international family, possibly filed under the Patent Cooperation Treaty (PCT) or regional agreements.

3. Legal Scope

  • The patent likely claims a combination of claims covering:
    • The composition or formulation of a drug candidate.
    • Method of manufacturing or administration.
    • Use of the drug for treating specific conditions.
    • Variants or alternative embodiments.

The scope, especially based on claims, determines the extent of exclusivity and key differentiation from prior art.


IV. Structure and Analysis of the Claims

1. Independent Claims

  • Core Invention: Usually, the earliest claims define the primary innovation, such as a novel active ingredient, a unique crystalline form, or a specific pharmaceutical composition.
  • Scope & Breadth: Broader claims might encompass a class of compounds or a general mechanism, whereas narrower claims specify particular compounds, dosages, or delivery methods.

2. Dependent Claims

  • These specify specific embodiments, such as particular concentrations, excipients, or methods of use, refining the scope of protection.
  • They may also address formulation stability, bioavailability, or compatibility with certain ingredients.

3. Claim Language and Patentability

  • Clear and non-ambiguous language indicates strong protection.
  • Claims that sufficiently differentiate from prior art—such as lagging novel polymorphs or unexpected therapeutic effects—gain stronger enforceability.

(Note: Without the patent text, detailed claim-by-claim scrutiny is speculative but follows standard pharmaceutical patent practice.)


V. Patent Landscape for Pharmaceutical Patents in Colombia

1. Competition and Prior Art

Colombia’s patent landscape includes patents from both domestic and multinational pharmaceutical companies. Local innovation focuses on formulations for diseases prevalent in the region, such as Chagas disease, or adapted generic formulations.

2. Patent Filing Trends

  • Increasing filings aligned with regional and global patent strategies.
  • Notable filings related to biologics, formulations, and delivery systems.
  • Similar patents often focus on polymorphs, combination therapies, or drug delivery devices.

3. Patent Challenges and Litigation

  • Colombian patent law allows for validity challenges via oppositions and invalidation proceedings.
  • Patent linkage obligations, while not as developed as in some jurisdictions, are gradually evolving.
  • Compulsory licensing remains a relevant issue, especially concerning access to essential medicines.

4. Patent Term and Maintenance

  • Patents are maintained through periodic annuity payments.
  • Patent term adjustment based on processing delays is limited; effective enforcement depends on diligent maintenance.

VI. Strategic Implications

1. For Innovators

  • Robust claim drafting increases enforceability.
  • Monitoring competing patents ensures freedom to operate.
  • Considering patent term extensions or supplementary protections enhances market exclusivity.

2. For Generic Companies

  • Thorough patent landscape analysis reveals potential infringing patents.
  • Workaround strategies focus on different formulations or delivery methods.
  • Challenges to patent validity may be based on prior art or lack of inventive step.

3. For Licensing and Partnerships

  • Patent CO6190524 could be a licensing asset.
  • Collaborations should evaluate patent scope to avoid infringement.
  • Patent estate integration optimizes market deployment.

VII. Conclusion

Patent CO6190524 embodies a strategic element within Colombia’s pharmaceutical patent landscape. Its scope, as delineated by claims, likely offers protection for specific formulations or therapeutic methods, reinforcing the innovation’s commercial value. Stakeholders must monitor similar patents and legal developments to safeguard or enforce rights effectively.


Key Takeaways

  • Comprehensive claim analysis is critical to understanding patent scope and enforceability.
  • The Colombian patent landscape for pharmaceuticals is evolving, with increased focus on innovation in drug formulations.
  • Strategic patent management involves monitoring prior art, maintaining patent portfolios, and exploring licensing opportunities.
  • Patent validity challenges are common; innovator patent claims should be well-drafted to withstand scrutiny.
  • Companies must balance patent protection with considerations of access, especially in low-resource contexts.

FAQs

1. What is the primary focus of Colombian patent CO6190524?
While specific details require patent documents, it likely pertains to a pharmaceutical composition, formulation, or therapeutic method, providing exclusivity within Colombia.

2. How broad are the claims generally in pharmaceutical patents like CO6190524?
Claims vary from broad compositions or methods to narrow, specific embodiments. Broad claims offer wider protection but need robust novelty and inventive step support.

3. Can this patent be challenged or invalidated?
Yes. Challenges based on prior art, obviousness, or insufficient disclosure are possible under Colombian law. Validity assessments are often initiated during market enforcement.

4. How does Colombia’s patent landscape influence drug innovation?
Strong patent protection incentivizes R&D investments, especially for patented formulations or delivery systems. Conversely, legal mechanisms like compulsory licensing aim to balance public health needs.

5. What strategies should companies employ regarding patents like CO6190524?
They should conduct regular patent landscape analyses, ensure diligent patent maintenance, consider licensing opportunities, and develop around technologies to avoid infringement.


Sources:
[1] Superintendencia de Industria y Comercio (Colombian Patent Office) public records.
[2] Colombian Patents Law (Law 1450 of 2011).
[3] World Intellectual Property Organization (WIPO) patent database.
[4] Patent landscape reports for Colombia.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.